L Ponce

Statistics

Publications

Citations

246

H-Index

Active since

2016

Affiliations

University of California San Diego(Current)

Galapagos (Belgium)

Desert Medical Imaging

L Ponce is an author at University of California San Diego specializing in response assessment, rheumatoid arthritis therapy, and clinical pharmacology.

ORCID

Publications per year

2016–2016

Publications

Filgotinib (GLPG0634/GS-6034), an oral selective JAK1 inhibitor, is effective as monotherapy in patients with active rheumatoid arthritis: results from a randomised, dose-finding study (DARWIN 2)

Arthur Kavanaugh, Joel M. Kremer, L Ponce et al. · Annals of the Rheumatic Diseases · 2016 · 230 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

THU0173 Filgotinib (GLPG0634), An Oral Jak1 Selective Inhibitor Is Effective as Monotherapy in Patients with Active Rheumatoid Arthritis: Results from A 24-Week Phase 2B Dose Ranging Study

Arthur Kavanaugh, L Ponce, Regina Cseuz et al. · Annals of the Rheumatic Diseases · 2016 · 16 citations

Medicine, Pharmacology, Pharmacotherapy +14

1–2 of 2